Skadden Reps McKesson In $2B US Oncology Deal

Law360, New York (November 1, 2010, 4:37 PM EDT) -- McKesson Corp., the largest pharmaceuticals distributor in the U.S., said Monday that it has agreed to buy US Oncology Inc. in a $2.16 billion deal that includes the assumption of the integrated oncology company's debt.

The companies said they have signed a definitive agreement under which McKesson will purchase all outstanding shares of The Woodlands, Texas-based US Oncology for cash. The deal is expected to close by the end of the year.

“Community oncology practices need strategic support that offers not only technology and distribution solutions,...
To view the full article, register now.